Assessing the value of interim analyses in clinical trials - PMLiVE

lt;p>Why its important and when its needed</p>

Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways - Faulkner - 2016 - Clinical Pharmacology & Therapeutics - Wiley Online Library

When is it feasible to do an interim analysis in a clinical trial?

Pharmafocus November 2023

Vaccines, Free Full-Text

image_004.jpg

Meds pipeline monitor 2022

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID

lantern_logo.jpg

image_006.jpg

AstraZeneca to stop post-marketing study of Andexxa following early success - PMLiVE

CLINICAL STUDY REPORTING - Assessing the Value of Interim Analyses in Clinical Trials

image_005.jpg

Digital R&D and the future of clinical development

Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways - Faulkner - 2016 - Clinical Pharmacology & Therapeutics - Wiley Online Library